Evaluation of Vaginal PAMG-1 Detection by PartoSure Test in Preterm Delivery Threat in Actual Clinical Situation: Randomized Controlled Trial

NACompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

December 11, 2018

Primary Completion Date

February 23, 2021

Study Completion Date

February 23, 2021

Conditions
Pregnancy Preterm
Interventions
OTHER

Current care

Tocolysis and a complete corticosteroid treatment.

DEVICE

PartoSure Test negative

Biochemical test and nifedipine tocolysis, then return at home with the midwife's visit at home twice a week up to 34 weeks of amenorrhea .

DEVICE

PartoSure Test positive

Biochemical test and tocolysis and a complete corticosteroid treatment. then if situation is stable, return at home with the midwife's visit at home twice a week up to 34 weeks of amenorrhea

Trial Locations (1)

29609

CHRU Brest, Brest

All Listed Sponsors
lead

University Hospital, Brest

OTHER

NCT03675061 - Evaluation of Vaginal PAMG-1 Detection by PartoSure Test in Preterm Delivery Threat in Actual Clinical Situation: Randomized Controlled Trial | Biotech Hunter | Biotech Hunter